Tatva Chintan Pharma Chem reports consolidated Q2 FY26 PAT at Rs. 9.91 Cr
News

Tatva Chintan Pharma Chem reports consolidated Q2 FY26 PAT at Rs. 9.91 Cr

Tatva Chintan Pharma Chem has reported total income of Rs. 124.52 crore during the period ended September 30, 2025

  • By IPP Bureau | November 02, 2025

Tatva Chintan Pharma Chem Ltd has reported consolidated financial results for the period ended September 30, 2025.

Tatva Chintan Pharma Chem has posted net profit of Rs. 9.91 crore for the period ended September 30, 2025 as against net profit of Rs. 6.65 crore for the period ended June 30, 2025. The company posted net loss of Rs. 0.66 crore for the period ended September 30, 2024.

Tatva Chintan Pharma Chem has reported total income of Rs. 124.52 crore during the period ended September 30, 2025 as compared to Rs. 118.01 crore during the period ended June 30, 2025. The company reported total income of Rs. 83.86 crore during the period ended September 30, 2024.

For the Half Year ended September 30, 2025, Tatva Chintan Pharma Chem has reported total income of Rs. 242.54 crore as compared to Rs. 190.50 crore during the 6 months period ended September 30, 2024.

The company has posted net profit of Rs. 16.56 crores for the 6 months period ended September 30, 2025 as against net profit of Rs. 4.54 crore for the 6 months period ended September 30, 2024.

Upcoming E-conference

Other Related stories

Startup

Digitization